There has been a new clinical trial that has provided new data that has demonstrated that back pain patients monitored and treated using wearable movement sensors had a significant and sustained improvement in pain and functional ability. The study reports on the 12 month, multicentre, cluster randomized, placebo controlled clinical trial sponsored by dorsaVi and the Victorian government, and involves 112 patients.
Read the full story here :: Clinical trial using dorsaVi sensors demonstrates signifiernt reduction in back pain
